Literature DB >> 4018651

Endoscopic variceal pressure measurements: response to isosorbide dinitrate.

J Dawson, P Gertsch, F Mosimann, R West, E Elias.   

Abstract

An endoscopic pressure sensor has been evaluated in the measurement of oesophageal variceal pressure and its response to drug ingestion. The variceal pressure showed a highly significant correlation with the splenic pulp pressure (r = 0.97) in six patients with liver disease of diverse aetiology and with hepatic venous wedge pressure (r = 0.92) in eight alcoholic cirrhotic men. Intraduodenal infusion of isosorbide dinitrate in the cirrhotics produced no change in wedge pressure or endoscopic variceal pressure despite profound falls in arterial systolic pressure. Thus isosorbide dinitrate appears to be of no value in treating portal hypertension. This study establishes the endoscopic pressure sensor as a valuable tool in screening drugs in this condition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018651      PMCID: PMC1432793          DOI: 10.1136/gut.26.8.843

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Wedged and free hepatic venous pressure measured with a balloon catheter.

Authors:  R J Groszmann; M Glickman; A T Blei; E Storer; H O Conn
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

2.  Precipitation of hepatic encephalopathy by propranolol in cirrhosis.

Authors:  D Tarver; R P Walt; A A Dunk; W J Jenkins; S Sherlock
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-27

3.  Propranolol in the treatment of portal hypertension: a caution.

Authors:  H O Conn
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

4.  [Measurement of pressure of esophageal varices by bloodless endoscopic approach].

Authors:  R Mosimann
Journal:  Helv Chir Acta       Date:  1981-04

5.  Propranolol increases arterial ammonia in liver cirrhosis.

Authors:  H R van Buuren; P C van der Velden; G Koorevaar; J Silberbusch
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

6.  Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects.

Authors:  T Taylor; L F Chasseaud; E Doyle; A Darragh; D A O'Kelly; D Fitzgerald
Journal:  Biopharm Drug Dispos       Date:  1980 Jan-Mar       Impact factor: 1.627

7.  Effects of sodium nitroprusside, isosorbide dinitrate, isoproterenol, phentolamine and prazosin on hepatic venous responses to sympathetic nerve stimulation in the cat.

Authors:  C V Greenway
Journal:  J Pharmacol Exp Ther       Date:  1979-04       Impact factor: 4.030

8.  Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.

Authors:  R J Groszmann; D Kravetz; J Bosch; M Glickman; J Bruix; J Bredfeldt; H O Conn; J Rodes; E H Storer
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

9.  Propranolol--a medical treatment for portal hypertension?

Authors:  D Lebrec; O Nouel; M Corbic; J P Benhamou
Journal:  Lancet       Date:  1980-07-26       Impact factor: 79.321

10.  Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.

Authors:  D Lebrec; T Poynard; P Hillon; J P Benhamou
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

View more
  10 in total

1.  UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology.

Authors:  R Jalan; P C Hayes
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  The significance of esophageal variceal pressure in patients with cirrhosis.

Authors:  T Yoshida; T Bandoh; S Kitano; K Shuto; K Ninomiya; Y Mitarai; M Kobayashi
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Comparison of portal pressure with intravascular esophageal variceal pressure (IEVP) directly measured with a flexible indwelling needle.

Authors:  A Watari; K Miyata; H Kanazawa; M Kobayashi
Journal:  Gastroenterol Jpn       Date:  1993-10

4.  Noninvasive variceal pressure measurement may be useful for predicting effect of sclerotherapy for esophageal varices.

Authors:  K Ueno; M Hashizume; M Ohta; M Tomikawa; S Kitano; K Sugimachi
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

5.  Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.

Authors:  A L Jones; I H Bangash; J Walker; K J Simpson; N D Finlayson; P C Hayes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 6.  Mechanisms and consequences of portal hypertension.

Authors:  P M MacMathuna
Journal:  Drugs       Date:  1992       Impact factor: 9.546

7.  Effect of Valsalva's manoeuvre and hyoscinbutylbromide on the pressure gradient across the wall of oesophageal varices.

Authors:  S W Hosking; P Robinson; A G Johnson
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

8.  Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis.

Authors:  S K Sarin; K K Sethi; R Nanda
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

9.  Effect and mechanism of action of isosorbide-5-mononitrate.

Authors:  P C Hayes; D Westaby; R Williams
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

10.  U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.

Authors:  Dhiraj Tripathi; Adrian J Stanley; Peter C Hayes; David Patch; Charles Millson; Homoyon Mehrzad; Andrew Austin; James W Ferguson; Simon P Olliff; Mark Hudson; John M Christie
Journal:  Gut       Date:  2015-04-17       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.